Skip to Content

WVCTSI Response to COVID-19

Image of COVID-19(UPDATED 3/19/2020)

WVCTSI shifting to virtual office in response to COVID-19

The West Virginia Clinical and Translational Science Institute headquarters based at West Virginia University has shifted to a remote office and cancelled or postponed gatherings/human contact in order to mitigate community spread of COVID-19. This decision was made in accordance with recommendations from officials across the state and partnering academic institutions, as well as federal guidance.

WVCTSI resources and services will still be available to investigators in adjusted remote/virtual formats. Consultations, meetings, and other activities will be offered through a variety of telecommunications and videoconferencing platforms.

Service requests and virtual meetings can be arranged with all staff members via email. Complete contact information for WVCTSI staff members can be found at WVCTSI.org

Our goal is to ensure that investigators are able to continue to pursue the mission of driving meaningful health outcomes through innovative biomedical research, while also minimizing the potential spread of the COVID-19 throughout the Mountain State.

WVCTSI will continue to share updates and information relevant to members as it becomes available. Members can also stay connected with WVCTSI on Facebook and Twitter. We appreciate your patience and flexibility as we react to this fluid situation.

 

WVCTSI COVID-19 Data Funding

WVCTSI Pop-Up COVID-19 Funding Opportunity

Guidance for Clinical Trial Principal Investigators

Guidance for WVU Investigators and Research Coordinators

Additional Recommendations for WVU Clinical Research

WVU COVID-19 Updates

Marshall University COVID-19 Updates

WVSOM COVID-19 Updates

COGR- Institutional and Agency Responses to COVID-19 and Additional Resources

NIDA COVID-19 Funding Opportunity

FDA Guidance on Clinical Trials